iiinova — where your digital self keeps evolving

Markus Eckstein

@markuseckstein3.bsky.social

Pathologist, Translational Cancer Researcher, Biomarker Enthusiast #advance biology centered cancer care Settled at Surgical and Molecular Pathology, University Hospital Erlangen @FAU Erlangen-Nürnberg

Posts Replies Media

Markus Eckstein @markuseckstein3.bsky.social · 11/12/2024

Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase 1b/2 dose-escalation and dose-expansion study www.annalsofoncology.org/article/S092...

030

Markus Eckstein @markuseckstein3.bsky.social · 29/11/2024

Incredible improvement for patient with microsatellite unstable metastatic colorectal cancer. MSI is a Ferrari ride for cancer evolution, but immunotherapy is the perfect match to stop that ride !!! Don’t think that we will see similar success for other „biomarkers“ soon. nej.md/4eGp1tj

021

Markus Eckstein @markuseckstein3.bsky.social · 29/11/2024

Nice overview on "Emerging ADCs for platinum-refractory UC" from #BLADDR in Vienna! 🚨 ADCs and small molecules came to stay and will likely advance cancer treatment of multiple cancers significantly !

011

Markus Eckstein @markuseckstein3.bsky.social · 20/11/2024

Differential diagnosis of abdominal pain

011